Polymorphism	Men							Women
Polymorphism	Control n (%)	ADC n (%)	OR (95% CI)	p	SCC n (%)	OR (95% CI)	p	Control n (%)	ADC n (%)	OR (95% CI)	p	SCC n (%)	OR (95% CI)	p
VEGF −634C > G	n = 295	n = 64			n = 117			n = 88	n = 44			n = 8
GG	150 (50.9)	33 (51.6)	1.00	0.23	61 (52.1)	1.00	0.09	48 (54.5)	18 (40.9)	1.00	0.27	6 (75.0)	1.00	0.24
GC	133 (45.1)	25 (39.1)	0.85 (0.48 - 1.51)		45 (38.5)	0.83 (0.53 - 1.31)		35 (3.8)	24 (54.5)	1.83 (0.86 - 3.87)		1 (12.5)	0.23 (0.03 - 1.98)
CC	12 (4.1)	6 (9.4)	2.27 (0.80 - 6.49)		11 (9.4)	2.25 (0.94 - 5.38)		5 (5.7)	2 (4.5)	1.07 (0.19 - 6.00)		1 (12.5)	1.60 (0.16 - 16.10)
GC + CC	145 (49.1)	31 (48.4)	0.97 (0.57 - 1.67)	0.92	56 (47.9)	0.95 (0.62 - 1.46)	0.81	40 (45.5)	26 (59.1)	1.73 (0.83 - 3.61)	0.14	2 (2.05)	0.40 (0.08 - 2.09)	0.25
VEGF −2578C > A	n = 295	n = 64			n = 117			n = 88	n = 44			n = 8
CC	65 (22.0)	16 (25.0)	1.59 (0.69 - 3.67)	0.47	39 (33.3)	1.00		21 (23.9)	10 (22.7)	1.37 (0.45 - 4.12)	0.52	2 (25.0)	0.55 (0.09 - 3.30)	0.30
CA	159 (53.9)	37 (57.8)	1.50 (0.72 - 3.11)		50 (42.7)	0.52 (0.32 - 0.87)	0.05	44 (50.0)	26 (59.1)	1.70 (0.66 - 4.35)		2 (25.0)	0.26 (0.04 - 1.54)
AA	71 (24.1)	11 (17.2)	1.00		28 (23.9)	0.66 (0.36 - 1.19)		23 (26.1)	8 (18.2)	1.00		4 (50.0)	1.00
CA+ AA	230 (78.0)	48 (75.0)	0.85 (0.45 - 1.59)	0.73	78 (66.7)	0.57 (0.35 - 0.91)	0.02	67 (76.1)	34 (77.3)	1.07 (0.45 - 2.52)	0.88	6 (75.0)	0.94 (0.17 - 5.02)	0.94
VEGF +936C > T	n = 295	n = 64			n = 117			n = 88	n = 44			n = 8
CC	217 (73.6)	51 (79.7)	1.00	0.56	74 (63.2)	1.00	0.08	59 (67.0)	28 (63.6)	1.00	0.51	5 (62.5)	1.00	0.20
CT	70 (23.7)	12 (18.8)	0.73 (0.37 - 1.45)	0.56	36 (30.8)	1.51 (0.93 - 2.44)		24 (27.3)	15 (34.1)	1.32 (0.60 - 2.89)		1 (12.5)	0.49 (0.05 - 4.43)
TT	8 (2.7)	1 (1.6)	0.53 (0.07 - 4.35)	0.56	7 (6.0)	2.57 (0.90 - 7.32)		5 (5.7)	1 (2.3)	0.42 (0.05 - 3.78)		2 (25.0)	4.72 (0.72 - 30.84)
CT + TT	78 (26.4)	13 (20.3)	0.71 (0.37 - 1.37)	0.30	43 (36.8)	1.62 (1.02 - 2.55)	0.04	29 (33.0)	16 (36.4)	1.16 (0.54 - 2.48)	0.70	3 (37.5)	1.22 (0.27 - 5.46)	0.80